Charles Schwab Investment Management Inc Anixa Biosciences Inc Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 12,785 shares of ANIX stock, worth $42,957. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,785
Previous 12,785
-0.0%
Holding current value
$42,957
Previous $28,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ANIX
# of Institutions
60Shares Held
5.56MCall Options Held
21KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.68 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$2.25 Million0.02% of portfolio
-
Laird Norton Trust Company, LLC621KShares$2.09 Million0.26% of portfolio
-
Ubs Group Ag529KShares$1.78 Million0.0% of portfolio
-
Mission Wealth Management, LP510KShares$1.71 Million0.04% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $103M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...